Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist originally approved by the FDA for type 2 diabetes under the brand name Mounjaro and subsequently approved for chronic weight management as Zepbound
Is Lipo-C approved for human use
Canadian-Based Fulfillment Fast domestic shipping from within Canada, reducing transit times and customs delays
No significant interaction between the reduction in HbA1c levels and baseline BMI was observed in the subgroup analysis of the PIONEER program [24]
Over time, this creates a positive feedback loop where weight loss further improves leptin sensitivity, making it easier to maintain the progress youve achieved
